KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
600201 Jinyu Bio-Technology
- 7.84
- +0.44+5.95%
Market Closed Dec 13 15:00 CST
8.78BMarket Cap53.33P/E (TTM)
8.14High7.49Low1.41MlotVolume7.55Open7.40Pre Close1.11BTurnover12.55%Turnover Ratio30.99P/E (Static)1.12BShares10.9452wk High1.62P/B8.78BFloat Cap5.6252wk Low8.14Limit Up1.12BShs Float30.78Historical High6.66Limit Down8.78%Amplitude-1.32Historical Low0.08Dividend TTM7.91Avg Price625.52KlotAsk1.02%Div YieldTTM100Lot Size750.08KlotBid
Jinyu Bio-Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -18.65%936.11M | -9.41%640.22M | 11.91%298.53M | 8.47%1.52B | 17.11%1.15B | 23.38%706.71M | 21.14%266.76M | -16.18%1.4B | -11.14%982.54M | -18.80%572.77M |
| Refunds of taxes and levies | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -40.83%4.92M | ---- |
| Cash received relating to other operating activities | -31.11%73.1M | -35.70%40.58M | -27.24%15.37M | 63.66%245.62M | 24.00%106.12M | 16.92%63.11M | -34.09%21.13M | 34.49%150.08M | 5.70%85.58M | -15.34%53.98M |
| Cash inflows from operating activities | -19.70%1.01B | -11.56%680.8M | 9.04%313.91M | 13.80%1.77B | 17.13%1.26B | 22.83%769.82M | 14.12%287.89M | -13.02%1.55B | -10.20%1.07B | -18.51%626.75M |
| Goods services cash paid | -38.89%277.48M | -33.34%181.21M | -37.42%80.58M | -11.43%384.72M | 16.07%454.09M | 1.09%271.85M | 57.90%128.75M | -13.10%434.38M | -13.56%391.23M | -21.94%268.91M |
| Staff behalf paid | 4.37%180.64M | 11.19%131.65M | 11.35%79.75M | 3.21%235.87M | -0.17%173.09M | -3.53%118.4M | -4.27%71.62M | 6.48%228.54M | 4.54%173.38M | 4.39%122.73M |
| All taxes paid | -22.80%81.35M | -26.03%63.15M | -40.15%26.18M | 32.95%141.79M | 28.02%105.38M | 34.07%85.37M | 45.76%43.75M | -7.76%106.65M | -4.30%82.31M | -8.80%63.67M |
| Cash paid relating to other operating activities | 12.97%258.46M | 13.35%174.06M | 3.28%81.7M | 34.38%592.3M | 6.24%228.78M | 16.83%153.56M | -9.63%79.11M | 3.81%440.76M | -7.45%215.34M | -16.40%131.43M |
| Cash outflows from operating activities | -17.00%797.94M | -12.57%550.07M | -17.02%268.21M | 11.93%1.35B | 11.49%961.34M | 7.23%629.17M | 18.01%323.23M | -3.54%1.21B | -7.99%862.26M | -14.85%586.74M |
| Net cash flows from operating activities | -28.49%211.28M | -7.05%130.73M | 229.28%45.69M | 20.36%414.83M | 40.18%295.45M | 251.59%140.65M | -63.36%-35.34M | -35.35%344.65M | -18.23%210.77M | -50.02%40M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --10.5M | ---- | ---- | ---- | ---- | ---- | ---- | -38.15%20M | 900.00%20M | --20M |
| Cash received from returns on investments | 162.58%28.26M | 636.37%28.26M | --551.52K | -32.57%24.2M | 440.85%10.76M | 93.05%3.84M | ---- | 253.18%35.88M | -71.94%1.99M | -56.10%1.99M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --793.98K | --766.12K | --760K | -97.80%5.7K | ---- | ---- | ---- | -52.40%258.93K | -80.58%398.72K | -80.96%380.81K |
| Cash received relating to other investing activities | 127.30%333.68M | 303.36%332.7M | 57.57%82.7M | -55.78%177.16M | -29.68%146.8M | -42.30%82.48M | -47.74%52.48M | -45.67%400.66M | -52.61%208.76M | -62.87%142.96M |
| Cash inflows from investing activities | 136.88%373.24M | 319.05%361.73M | 60.07%84.01M | -55.92%201.36M | -31.84%157.57M | -47.79%86.32M | -56.64%52.48M | -41.48%456.8M | -48.82%231.15M | -57.77%165.33M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -58.57%64.13M | -36.54%44.48M | -1.42%33.56M | 43.69%273.17M | 13.02%154.8M | -26.08%70.09M | -23.26%34.04M | -48.99%190.11M | -46.52%136.97M | -41.46%94.82M |
| Cash paid to acquire investments | --4.46M | --456.81K | --456.81K | ---- | ---- | ---- | ---- | 9,971.00%10.07M | ---- | ---- |
| Cash paid relating to other investing activities | 150.96%602.32M | 1,874.38%592.32M | 10.00%11M | 735.39%668.31M | 500.00%240M | --30M | --10M | -91.63%80M | -81.41%40M | ---- |
| Cash outflows from investing activities | 69.93%670.9M | 536.69%637.25M | 2.21%45.01M | 236.03%941.48M | 123.09%394.8M | 5.56%100.09M | -0.72%44.04M | -78.91%280.18M | -62.45%176.97M | -76.71%94.82M |
| Net cash flows from investing activities | -25.47%-297.66M | -1,901.18%-275.52M | 361.87%39M | -519.05%-740.11M | -537.82%-237.24M | -119.53%-13.77M | -88.99%8.44M | 132.22%176.62M | 375.23%54.19M | 550.52%70.51M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --17.15M | --17.15M | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --17.15M | --17.15M | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --60M | --60M | --60M |
| Cash received relating to other financing activities | -96.28%7.35M | -97.54%4.72M | --1.17M | 1,640.55%200.53M | --197.31M | --192.07M | ---- | -12.17%11.52M | ---- | ---- |
| Cash inflows from financing activities | -96.57%7.35M | -97.54%4.72M | --1.17M | 204.35%217.68M | 257.42%214.46M | 220.10%192.07M | ---- | 445.25%71.52M | 357.42%60M | --60M |
| Borrowing repayment | ---- | ---- | ---- | --10M | --10M | --10M | --10M | ---- | ---- | ---- |
| Dividend interest payment | 33.02%89.2M | ---- | ---- | -46.29%66.81M | -45.79%67.06M | 2,112.79%67.06M | 54.04%60.97K | -7.34%124.38M | -5.87%123.71M | -97.47%3.03M |
| Cash payments relating to other financing activities | -41.47%14.96M | -56.55%9.81M | 1,571.30%2.67M | -92.33%29.5M | -92.03%25.56M | -91.09%22.59M | --159.51K | 17,623.10%384.44M | 57,585.19%320.65M | --253.59M |
| Cash outflows from financing activities | 1.50%104.16M | -90.15%9.81M | -73.92%2.67M | -79.11%106.31M | -76.91%102.62M | -61.17%99.65M | 25,722.20%10.22M | 273.04%508.82M | 236.67%444.37M | 113.84%256.62M |
| Net cash flows from financing activities | -186.57%-96.82M | -105.51%-5.09M | 85.40%-1.49M | 125.47%111.38M | 129.10%111.84M | 147.00%92.42M | -202.61%-10.22M | -254.72%-437.29M | -223.35%-384.36M | -63.84%-196.62M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 5,341.40%19.58K | 45.91%-10.72K | -103.73%-5.11K | -100.25%-246.92 | -99.83%359.79 | -110.92%-19.82K | --137.16K | 217.88%99.05K | 1,913.38%207.45K | 931.19%181.5K |
| Net increase in cash and cash equivalents | -207.72%-183.18M | -168.36%-149.9M | 324.94%83.19M | -354.42%-213.9M | 242.67%170.06M | 355.20%219.28M | -156.89%-36.98M | 160.75%84.07M | -200.00%-119.2M | -54.41%-85.92M |
| Add:Begin period cash and cash equivalents | -16.89%1.05B | -16.89%1.05B | -16.89%1.05B | 7.11%1.27B | 7.11%1.27B | 7.11%1.27B | 7.11%1.27B | -10.48%1.18B | -10.48%1.18B | -10.48%1.18B |
| End period cash equivalent | -39.47%869.58M | -39.24%902.86M | -7.62%1.14B | -16.89%1.05B | 35.11%1.44B | 35.50%1.49B | -1.44%1.23B | 7.11%1.27B | -26.16%1.06B | -13.33%1.1B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
